{"id":"W2283622962","doi":"10.1016/j.jaad.2016.01.013","title":"Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":155,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Plaque psoriasis; Open label; Term (time); Psoriasis; Dermatology; Randomized controlled trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01374798,0.001785876,0.002828364,0.0006740713,0.0006240669,0.001388406,0.001043341,0.002082498,0.002979477],"category_scores_gemma":[0.007343289,0.0008816532,0.004107873,0.0008228351,0.001388363,0.001413458,0.0006343044,0.002994627,0.0004882351],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009851622,"about_ca_system_score_gemma":0.001723237,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005883264,"about_ca_topic_score_gemma":0.001448807,"domain_scores_codex":[0.9954164,0.002883669,0.0004274284,0.0004808091,0.0004847763,0.0003069878],"domain_scores_gemma":[0.9925021,0.002300248,0.002562839,0.0006996876,0.0005920802,0.001343121],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9358045,0.01167469,0.005223751,0.0009807857,0.004410207,0.00008602899,0.0001290279,0.0003764712,0.006574942,0.00007535307,0.0009309952,0.03373324],"study_design_scores_gemma":[0.9045801,0.07553663,0.01454167,0.00009183712,0.002727044,0.0001392331,0.0000282311,0.0002836695,0.0009418848,0.0001243838,0.0009689934,0.00003631935],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.974436,0.0157588,0.001609067,0.0006808367,0.0002549726,0.003946727,0.002259947,0.00008991267,0.0009636341],"genre_scores_gemma":[0.9769158,0.008040814,0.002984817,0.001237241,0.0008289726,0.004741183,0.003973711,0.00004504037,0.001232305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01374798,"threshold_uncertainty_score":0.07270718,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05819594020406633,"score_gpt":0.362165703951438,"score_spread":0.3039697637473717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}